The Department of Justice reached an $8.3 billion settlement with OxyContin-maker Purdue Pharma, but the administration’s proposed budget includes cuts that could reduce addiction coverage as substance use spikes during the pandemic.
Trump Administration Sends Mixed Messages On Combating Opioid Epidemic, As Election Looms
